ClinicalThought


Share

Program Content

Activities

  • FAQs: EGFRmut NSCLC
    Evolving Treatment Landscape of EGFR-Mutated Advanced and Metastatic NSCLC: Answers to Frequently Asked Questions
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 28, 2024

    Expires: June 27, 2025

Faculty

cover img faculity

Nicolas Girard, MD, PhD

Professor
Chair of Medical Oncology
Head of the Thorax Institute Curie-Montsouris
Institut Curie
Universite Paris-Saclay
Paris, France

cover img faculity

Natasha Leighl, MD, MMSc, FRCPC, FASCO

Lung Medical Oncology Site Lead
OSI Pharmaceuticals Foundation Chair
Princess Margaret Cancer Centre
Professor of Medicine
University of Toronto
Toronto, Canada

cover img faculity

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director, Clinical Research
Clinical Professor, Department of Medicine
Cedars-Sinai
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Boehringer Ingelheim Pharmaceuticals, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC